H5N1 influenza virus and the safety of plasma products

Transfusion

Volumn 47, Issue 3, 2007, Pages 452-459

  Kreil, T R ^a   Unger, U ^a   Orth, S M ^a   Petutschnig, G ^a   Kistner, O ^a   Poelsler, G ^a   Berting, A ^a  

^a BAXTER BIOSCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BLOOD CLOTTING FACTOR 8 INHIBITOR; DETERGENT; IMMUNOGLOBULIN; SOLVENT;

ARTICLE; CONTROLLED STUDY; FREEZE DRYING; HEATING; INCUBATION TIME; INFLUENZA VIRUS A H5N1; NONHUMAN; PASTEURIZATION; PH; PLASMA TRANSFUSION; SAFETY; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS STRAIN; VIRUS TRANSMISSION;

ANIMALS; BLOOD TRANSFUSION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; CHICK EMBRYO; DISINFECTION; HEAT; HUMANS; HYDROGEN-ION CONCENTRATION; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; PLASMA; VERO CELLS; VIRUS INACTIVATION;

EID: 33847069096     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01135.x     Document Type: Article

References (19)

1. Webster RG, Peiris M, Chen H, Guan Y. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis, 2006;12:3-8.
2. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO [table on the Internet]. Geneva: World Health Organization; 2006 Aug 7. http://www.who.int/csr/disease/avian_influenza/country/ cases_table_2006_08_07/en/index.html
3. Seo SH, Hoffmann E, Webster RG. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002;8:950-4.
4. Govorkova EA, Rehg JE, Krauss S, et al. Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 2005;79:2191-8.
5. Uiprasertkul M, Puthavathana P, Sangsiriwut K, et al. Influenza A H5N1 replication sites in humans. Emerg Infect Dis 2005;11:1036-41.
6. de J, Bach VC, Phan TQ, et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005;352:686-91.
7. Advisory Committee on Blood Safety and Availability, Department of Health and Human Services, 26th Meeting Minutes, May 16 & 17, 2005 [monograph on the Internet]. Washington DC: U.S. Department of Health & Human Services; 2005. Available from: http://www.hhs.gov/bloodsafety/summaries/summay05.pdf
8. Stanley ED, Jackson GG. Viremia in Asian influenza. Trans Assoc Am Phys 1966;79:376-87.
9. Naficy K. Human influenza infection with proved viremia: report of a case. N Engl J Med 1963;269:964-6.
10. Lehmann NI, Gust ID. Viraemia in influenza: a report of two cases. Med J Aust 1971;2:1166-9.
11. Khakpour M, Saidi A, Naficy K. Proved viraemia in Asian influenza (Hong Kong variant) during incubation period. Br Med J 1969;4:208-9.
12. Chutinimitkul S, Bhattarakosol P, Srisuratanon S, et al. H5N1 influenza A virus and infected human plasma. Emerg Infect Dis 2006;12:1041-3.
13. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on plasma-derived medicinal products [monograph on the Internet]. CPMP/BWP/269/95 rev. 3. London: The European Agency for the Evaluation of Medicinal Products; 2001 Jan 25. Available from: http://www.emea.eu.int/pdfs/human/bwp/026995en.pdf
14. Committee for Proprietary Medicinal Products (CPMP). Note for guidance on virus validation studies: the design, contribution and interpretation of studies validating the inactivation and removal of viruses [monograph on the Internet]. CPMP/BWP/268/95. London: The European Agency for the Evaluation of Medicinal Products; 1996 Feb 14. Available from: http://www.emea.eu.int/pdfs/ human/bwp/026895en.pdf
15. Nicolson C, Major D, Wood JM, Robertson JS. Generation of influenza vaccine viruses on Vero cells by reverse genetics: an H5N1 candidate vaccine strain produced under a quality system. Vaccine 2005;23:2943-52.
16. Leikina E, Ramos C, Markovic I, Zimmerberg J, Chernomordik LV. Reversible stages of the low-pH-triggered conformational change in influenza virus hemagglutinin. EMBO J 2002;21:5701-10.
17. Scholtissek C. Stability of infectious influenza A viruses to treatment at low pH and heating. Arch Virol 1984;85:1-11.
18. Committee for Medicinal Products for Human Use (CHMP). Guideline on assessing the risk for virus transmission - new chapter 6 of the note for guidance on plasma derived medicinal products (CPMP/BWP/269/95) [monograph on the Internet]. CPMP/BWP/5180/03. London: The European Agency for the Evaluation of Medicinal Products; 2004 Oct 21. Available from: http://www.emea.eu.int/pdfs/ human/bwp/518003en.pdf
19. Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA. Virus taxonomy: classification and nomenclature of viruses - eighth report of the international committee on the taxonomy of viruses. San Diego: Elsevier/Academic Press;, 2005.